Literature DB >> 24092921

Ikaros' suspended flight in the thymus.

Naomi Taylor1, Valérie S Zimmermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24092921      PMCID： PMC3790498          DOI： 10.1182/blood-2013-08-519835

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.

Authors:  Kevin W Tinsley; Changwan Hong; Megan A Luckey; Joo-Young Park; Grace Y Kim; Hee-Won Yoon; Hilary R Keller; Andrew J Sacks; Lionel Feigenbaum; Jung-Hyun Park
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

2.  Genetic inactivation of Ikaros is a rare event in human T-ALL.

Authors:  Ambroise Marçais; Robin Jeannet; Lucie Hernandez; Jean Soulier; François Sigaux; Susan Chan; Philippe Kastner
Journal:  Leuk Res       Date:  2009-09-30       Impact factor: 3.156

3.  Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.

Authors:  L Sun; N Heerema; L Crotty; X Wu; C Navara; A Vassilev; M Sensel; G H Reaman; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation.

Authors:  N Avitahl; S Winandy; C Friedrich; B Jones; Y Ge; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

5.  Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.

Authors:  Julie A Urban; Susan Winandy
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

6.  Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.

Authors:  Philippe Kastner; Arnaud Dupuis; Marie-Pierre Gaub; Raoul Herbrecht; Patrick Lutz; Susan Chan
Journal:  Am J Blood Res       Date:  2013-01-17

7.  Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor.

Authors:  Peter Papathanasiou; Andrew C Perkins; Bradley S Cobb; Roger Ferrini; Rupa Sridharan; Gerard F Hoyne; Keats A Nelms; Stephen T Smale; Christopher C Goodnow
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

8.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

9.  Ikaros: master of hematopoiesis, agent of leukemia.

Authors:  Kara L Davis
Journal:  Ther Adv Hematol       Date:  2011-12

10.  A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma.

Authors:  S Winandy; P Wu; K Georgopoulos
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.